Diabetes, hyperglycaemia and mortality in disabled older women: The Women's Health and Ageing Study I

Diabetic Medicine

Volumn 22, Issue 5, 2005, Pages 543-550

  Blaum, Caroline S ^a,b   Volpato, S ^c   Cappola, A R ^d   Chaves, P ^b,e   Xue, Q L ^b   Guralnik, J M ^f   Fried, L P ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c UNIVERSITY OF FERRARA   (Italy)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^f NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Diabetes; Hyperglycaemia; Mortality

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

AGED; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; COMORBIDITY; CONFIDENCE INTERVAL; DEMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; ELDERLY CARE; EVALUATION; FEMALE; FOLLOW UP; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MEDICARE; MORTALITY; PHYSICAL DISABILITY; RISK; RISK BENEFIT ANALYSIS; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; BALTIMORE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DISABLED PERSONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERGLYCEMIA; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 17844371371     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2005.01457.x     Document Type: Article

References (41)

1. Roper N, Bilous R, Kelly W, Unwin N, Connolly V. Cause-specific mortality in a population with diabetes: South Tees Diabetes Mortality Study. Diabetes Care 2002; 25: 43-48.
2. Bertoni A, Krop J, Anderson G, Brancati F. Diabetes-related morbidity and mortality in a national sample of U.S. elders. Diabetes Care 2002; 25: 471-475.
3. Tierney EF, Geiss LS, Engelgau MM, Thompson TJ, Schaubert D, Shireley LA et al. Population-based estimates of mortality associated with diabetes: use of a death certificate check box in North Dakota. Am J Public Health 2001; 91: 84-92.
4. Rockwood K, Awalt E, MacKnight C, McDowell I. Incidence and outcomes of diabetes mellitus in elderly people: report from the Canadian Study of Health and Aging. Can Med Assoc J 2000; 162: 769-772.
5. Berger B, Stenstrom G, Sundkvist G. Incidence, prevalence, and mortality of diabetes in a large population. A report from the Skaraborg Diabetes Registry. Diabetes Care 1999; 22: 773-778.
6. Vilbergsson S, Sigurdsson G, Sigvaldason H, Sigfusson N. Coronary heart disease mortality amongst non-insulin-dependent diabetic subjects in Iceland: the independent effect of diabetes. The Reykjavik Study 17-year follow up. J Intern Med 1998; 244: 309-316.
7. Muggeo M, Verlato G, Bonora E, Bressan F, Girotto S, Corbellini M et al. The Verona diabetes study: a population-based survey on known diabetes mellitus prevalence and 5-year all-cause mortality. Diabetologia 1995; 38: 318-325.
8. Walters DP, Gatling W, Houston AC, Mullce MA, Julious SA, Hill RD. Mortality in diabetic subjects: an eleven-year follow-up of a community-based population. Diabet Med 1994; 11: 968-973.
9. Croxson SC, Price DE, Burden M, Jagger C, Burden AC. The mortality of elderly people with diabetes. Diabet Med 1994; 11: 250-252.
10. Stengard JH, Tuomilehto J, Pekkanen J, Kivinen P, Kaarsalo E, Nissinen A et al. Diabetes mellitus, impaired glucose tolerance and mortality among elderly men: the Finnish cohorts of the Seven Countries Study. Diabetologia 1992; 35: 760-765.
11. Knuiman MW, Welborn TA, Whittall DE. An analysis of excess mortality rates for persons with non-insulin-dependent diabetes mellitus in Western Australia using the Cox proportional hazards regression model. Am J Epidemiol 1992; 135: 638-648.
12. Waugh NR, Dallas JH, Jung RT, Newton RW. Mortality in a cohort of diabetic patients. Causes and relative risks. Diabetologia 1989; 32: 103-104.
13. Panzram G, Zabel-Langhennig R. Prognosis of diabetes mellitus in a geographically defined population. Diabetologia 1981; 20: 587-591.
14. Khaw KT, Wareham N, Luben R, Bingham S, Oakes W, Welch A et al. Glycated haemoglobin, diabetes and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk). Br Med J 2001; 322: 15-28.
15. Guralnik J, Fried L, Simonsick E, Kasper J, Lafferty M. The Women's Health and Aging Study: Health and Social Charactersitics of Older Women with Disability. NIH Pub. no. 95-4009. Bethesda, MD: National Institute on Aging, 1995.
16. Fried LP, Ettinger WH, Lind B, Newman AB, Gardin J. Physical disability in older adults: a physiological approach. Cardiovascular Health Study Research Group. J Clin Epidemiol 1994; 47: 747-760.
17. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental State'. A practical method of grading the cognitive status of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
18. Simonsick EM, Maffeo CE, Rogers SK, Skinner EA, Davis D, Guralnik JM et al. Methodology and feasibility of a home-based examination in disabled older women: the Women's Health and Aging Study. J Gerontol A Biol Sci Med Sci 1997; 52: M264-274.
19. Fried LP, Kasper J, Williamson JD, Skinner EA, Morris C, Hochberg M. Disease ascertainment algorithms. In Guralnik J, Fried LP, Simonsick EM, Kasper J, Lafferty M eds. The Women's Health and Aging Study: Health and Social Characteristics of Older Women with Disability. Appendix E. Bethesda, MD: National Institute on Aging, 1995.
20. Volpato S, Blaum CS, Resnick HE, Ferrucci L, Fried LP, Guralnik J. Comorbidities and impairments explaining the association between diabetes mellitus and lower extremity disability. The Women's Health and Aging Study. Diabetes Care 2002; 25: 678-683.
21. Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 1993; 88: 837-845.
22. Simonsick EM, Fried LP. Exercise tolerance and body composition. In Guralnik JM, Fried LP, Simonsick E, Kasper J, Lafferty M eds. The Women's Health and Aging Study: Health and Social Characteristics of Older Women with Disability. NIH Pub. No. 95-4009. Bethesda, MD: NIH, 1995; 106-117.
23. Fried LP, Kronmal RA, Newman AB, Bild DE, Mittelmark MB, Polak JF et al. Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA 1998; 279: 585-592.
24. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982; 17: 37-49.
25. Lyness JM, Noel TK, Cox C, King DA, Conwell Y, Caine ED. Screening for depression in elderly primary care patients. A comparison of the Center for Epidemiologic Studies-Depression Scale and the Geriatric Depression Scale. Arch Intern Med 1997; 157: 449-454.
26. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 1676-1685.
27. Volpato S, Guralnik J, Ferrucci L, Balfour J, Chaves P, Fried LP et al. Cardiovascular disease, interleukin-6, and risk of mortality in women: The Women's Health and Aging Study. Circulation 2001; 103: 947-953.
28. Agresti A. Categorical Data Analysis. New York: John Wiley and Sons, 1990.
29. SAS Institute. SAS Procedures Guide, Version 8, Vols 1 and 2. Cary, NC: SAS Institute, 2000.
30. Stata Corporation. Stata User's Guide. College Station, TX: Stata Press, 2001.
31. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998; 352: 837-852.
32. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995; 18: 258-268.
33. Allison DB, Gallagher D, Heo M, Pi-Sunyer FX, Heymsfield SB. Body mass index and all-cause mortality among people age 70 and over: the Longitudinal Study of Aging. Int J Obes Relat Metab Disord 1997; 21: 424-431.
34. Landi F, Zuccala G, Gambassi G, Incalzi RA, Manigrasso L, Pagano F et al. Body mass index and mortality among older people living in the community. J Am Geriatr Soc 1999; 47: 1072-1076.
35. Volpato S, Leveille SG, Corti MC, Harris TB, Guralnik JM. The value of serum albumin and high-density lipoprotein cholesterol in defining mortality risk in older persons with low serum cholesterol. J Am Geriatr Soc 2001; 49: 1142-1147.
36. Schatz IJ, Masaki K, Yano K, Chen R, Rodriguez BL, Curb JD. Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study. Lancet 2001; 358: 351-355.
37. Reuben DB, Ix JH, Greendale GA, Seeman TE. The predictive value of combined hypoalbuminemia and hypocholesterolemia in high functioning community-dwelling older persons. MacArthur Studies of Successful Aging. J Am Geriatr Soc 1999; 47: 402-406.
38. Gylling H, Strandberg T, Tilvis R, Miettinen TA. Regulation of serum cholesterol level in middle-aged and elderly men. Relation of cholesterol absorption and synthesis to lipoprotein metabolism. Arterioscler Thromb 1994; 14: 694-700.
39. Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care 1998; 21: 1138-1145.
40. Koskinen SV, Martelin TP, Valkonen T. Socioeconomic differences in mortality among diabetic people in Finland: five year follow up. Br Med J 1996; 313: 975-978.
41. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998; 21: 518-524.